Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.

Literature DB >> 30904830

Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.

Jin Kyun Park¹, Yunhee Choi², Kevin L Winthrop³, Yeong Wook Song¹, Eun Bong Lee⁴.

Abstract

Entities: Chemical Disease

Keywords: discontinuation; influenza; methotrexate; rheumatoid arthritis; vaccination

Mesh：

Substances：

Year: 2019 PMID： 30904830 DOI： 10.1136/annrheumdis-2019-215187

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. COVID-19 vaccination in immunocompromised patients.

Authors: Bhavin Sonani; Fawad Aslam; Amandeep Goyal; Janki Patel; Pankaj Bansal
Journal: Clin Rheumatol Date: 2021-01-11 Impact factor: 2.980

2. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.

Authors: Jeffrey R Curtis; Sindhu R Johnson; Donald D Anthony; Reuben J Arasaratnam; Lindsey R Baden; Anne R Bass; Cassandra Calabrese; Ellen M Gravallese; Rafael Harpaz; Andrew Kroger; Rebecca E Sadun; Amy S Turner; Eleanor Anderson Williams; Ted R Mikuls
Journal: Arthritis Rheumatol Date: 2022-05 Impact factor: 15.483

3. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?

Authors: Reinhart Speeckaert; Jo Lambert; Luis Puig; Marijn Speeckaert; Hilde Lapeere; Sofie De Schepper; Nanja van Geel
Journal: Drugs R D Date: 2021-06-09

Review 4. An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.

Authors: Louise M Gresham; Barbara Marzario; Jan Dutz; Mark G Kirchhof
Journal: J Am Acad Dermatol Date: 2021-01-19 Impact factor: 11.527

5. COVID-19 vaccination and antirheumatic therapy.

Authors: Jack Arnold; Kevin Winthrop; Paul Emery
Journal: Rheumatology (Oxford) Date: 2021-08-02 Impact factor: 7.580

Review 6. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review.

Authors: Mehmet Soy; Gökhan Keser; Pamir Atagunduz; Melek Yalçin Mutlu; Alper Gunduz; Gizem Koybaşi; Cemal Bes
Journal: Clin Rheumatol Date: 2021-03-22 Impact factor: 2.980

Review 7. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.

Authors: Christof Specker; Peer Aries; Jürgen Braun; Gerd Burmester; Rebecca Fischer-Betz; Rebecca Hasseli; Julia Holle; Bimba Franziska Hoyer; Christof Iking-Konert; Andreas Krause; Klaus Krüger; Martin Krusche; Jan Leipe; Hanns-Martin Lorenz; Frank Moosig; Rotraud Schmale-Grede; Matthias Schneider; Anja Strangfeld; Reinhard Voll; Anna Voormann; Ulf Wagner; Hendrik Schulze-Koops
Journal: Z Rheumatol Date: 2021-09-07 Impact factor: 1.372

8. BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.

Authors: Quentin Moyon; Delphine Sterlin; Makoto Miyara; François Anna; Guy Gorochov; Zahir Amoura; Alexis Mathian; Raphael Lhote; Pascale Ghillani-Dalbin; Paul Breillat; Sasi Mudumba; Sophia de Alba; Fleur Cohen-Aubart; Julien Haroche; Micheline Pha; Thi Huong Du Boutin; Hedi Chaieb; Pedro Macedo Flores; Pierre Charneau
Journal: Ann Rheum Dis Date: 2021-10-04 Impact factor: 19.103

9. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.

Review 10. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].